Kopran’s arm gets process patent for API product

13 Dec 2021 Evaluate

Kopran’s arm has received process patent for API product. The Indian Patent office has granted Process Patent for 20 years to Kopran Research Laboratories, Wholly owned Subsidiary of the Company for the Active Pharmaceutical Ingredient (API) product NITROXOLINE, for the invention titled ‘improved, cost effective process for producing NITROXOLINE’.

Kopran is engaged primarily in pharmaceuticals business.

Kopran Share Price

148.25 -2.05 (-1.36%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×